The US FDA has issued Establishment Inspection Report (EIR) for Company's Jeedimetla facility located at Hyderabad, Telangana, India.
This facility was inspected by US FDA in March 2018 and there was one (1) 483 observation during the inspection. The company has responded to the observation within the stipulated timeframe. Jeedimetla facility manufactures Active pharmaceutical ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs).
Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.94.65 as compared to the previous close of Rs. 92.6. The total number of shares traded during the day was 131288 in over 1157 trades.
The stock hit an intraday high of Rs. 96 and intraday low of 92. The net turnover during the day was Rs. 12382496.